Syed Saad Mahmood

Dr Mahmood is a Cardio-Oncologist – i.e., a cardiologist sub-specialized in preventing and treating cardiovascular toxicities of cancer therapies among active cancer patients and cancer survivors. His research focus is on cardiotoxicity of oncology immunotherapy such as immune checkpoint inhibitor-associated myocarditis, and he is the principal investigator of a multi-center registry of chimeric antigen receptor T-cell therapy. Dr Mahmood serves as the System Director of Cardio-Oncology at Catholic Health Services of Long Island, and prior to that was Founder/Interim Director of Cardio-Oncology Program at Weill Cornell Medicine. He has previously also been on faculty at Harvard Medical School and Memorial Sloan Kettering Cancer Center. He completed his internal medicine residency at Massachusetts General Hospital (MGH), Harvard Medical School, and his cardiovascular disease fellowship at Weill Cornell Medicine where he served as chief fellow. He also completed a two-year subspecialty fellowship in Cardio-Oncology at Brigham and Women's Hospital, and MGH, Harvard Medical School. He is a graduate of Case Western Medical School.